Serum Lactate Dehydrogenase Is a Novel Predictor for the Severity in the Patients With MAFLD: A Cross-Sectional Study in Hefei, China

Serum Lactate Dehydrogenase Is a Novel Predictor for the Severity in the Patients With MAFLD: A Cross-Sectional Study in Hefei, China

Liang Yu,1,* Shiming Bao,2,* Feng Zhu,3,* Yanyan Xu,1 Fuqiang Zu,1 Yanwei Liu,1 Runbeng Jiang,1 Wei Chen,4 Song Chen5 1Department of General Surgery, The Second Affiliated Hospital of Anhui Medical University, Hefei, People’s Republic of China; 2Department of Emergency Surger...

Full description

Saved in:
Bibliographic Details
Main Authors: Yu L, Bao S, Zhu F, Xu Y, Zu F, Liu Y, Jiang R, Chen S, Chen W
Format: Article
Language:English
Published: Dove Medical Press 2025-02-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
lactate dehydrogenase
obesity
metabolic syndrome
inflammation
metabolic associated fatty liver disease (mafld)
Online Access:https://www.dovepress.com/serum-lactate-dehydrogenase-is-a-novel-predictor-for-the-severity-in-t-peer-reviewed-fulltext-article-DMSO
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.dovepress.com/serum-lactate-dehydrogenase-is-a-novel-predictor-for-the-severity-in-t-peer-reviewed-fulltext-article-DMSO

Similar Items